Evidence map›Paper›PMID 19545475›Full record

Trial reportThe international journal of neuropsychopharmacology2009

Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.

Alan N Simmons, Estibaliz Arce, Kathryn L Lovero, Murray B Stein, Martin P Paulus

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The international journal of neuropsychopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00703885 (PharmacofMRI of Anxiolytic Medications), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00703885 phase4completednot on this map

PharmacofMRI of Anxiolytic Medications (Alprazolam)

TypeinterventionalSponsorUniversity of California, San DiegoRan2008 to 2008Enrolled16ConditionsAnxiety DisordersArms0.25 mg alprazolam, 1.0 mg alprazolam, placebo
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Trial
  4. Trial
  5. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  6. Trial
  7. The effects of sertraline on psychopathic traits.International clinical psychopharmacology · 2011
    Trial
  8. Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Trial
  9. Pregabalin influences insula and amygdala activation during anticipation of emotional images.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Observational
  14. [Therapeutic mechanism of hederagenin, an active component inNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  15. Amygdala-insula response to neutral stimuli and the prospective prediction of anxiety sensitivity.Progress in neuro-psychopharmacology & biological psychiatry · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alan N SimmonsUniversity of California, San Diego, CA 92161-0151B, USA. ansimmons@ucsd.edu
Estibaliz Arce
Kathryn L Lovero
Murray B Stein
Martin P Paulus
VA San Diego Healthcare System · USUniversity of California, San Diego · US

Funding

Neural Substrates of Decision-making in AnxietyR01MH065413 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2003 to 2011
$2.6M
Improving Patient Outcomes in Anxiety DisordersK24MH064122 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2001 to 2011
$1.3M
Pharmacological fMRI to Identify New Anxiolytics: A Human BioassayR01MH075792 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2006 to 2008
$1.0M
NIMH NIH HHS K24 MH064122NIMH NIH HHS MH075792NIMH NIH HHS MH64122NIMH NIH HHS MH65413NIMH NIH HHS R01 MH065413NIMH NIH HHS R01 MH075792
6 · The paper itself

Abstract

The anterior cingulate cortex (ACC) and insula are important neural substrates for the integration of cognitive, emotional, and physiological information, as well as the coordination of responses to anticipated stimuli. Increased neural activation within these structures has been observed in individuals with anxiety and depressive disorders. Selective serotonin reuptake inhibitors (SSRIs) are among the most effective and frequently prescribed anxiolytic agents, yet it is not known whether ACC or insula underlie the effects of these drugs. We examined whether subchronic administration of a SSRI to healthy volunteers attenuates activation in ACC or insula during anticipation, an important emotional process underlying anxiety. Support for this hypothesis would help to understand where and by what process SSRIs may exert beneficial effects as anxiolytics and would provide further mechanistic evidence for functional magnetic resonance imaging (fMRI) as a biomarker for the development of anxiolytics. Fifteen volunteers participated in a double-blind, placebo-controlled, randomized cross-over study. Participants completed a pleasant and aversive picture-cued anticipation task during fMRI after taking either escitalopram (10 mg) or placebo for 21 d. We found that escitalopram significantly decreased activation in bilateral posterior and middle insula during the anticipation condition irrespective of stimulus valence and in medial prefrontal and ACC during anticipation of aversive vs. pleasant images. Reduced insular and ACC activation in healthy controls during anticipation may be integral to the therapeutic efficacy of SSRIs and may provide a mechanistic approach for the use of pharmaco-fMRI in the identification of novel pharmacotherapeutic agents in patient populations.

Indexed as

AdultAttentionBrain MappingCerebral CortexCitalopramCross-Over StudiesDouble-Blind MethodEmotionsFemaleGyrus CinguliHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingNeuropsychological TestsOxygenPhotic StimulationCitalopramOxygenSelective Serotonin Reuptake Inhibitors

Identifiers

PMID19545475
PMCPMC2846821
OpenAlexW2106811231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.